SENSICARDIAC vs Us2.ca
Similar category, different focus. These tools serve overlapping but distinct needs.
Comparability 60/100
Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
AI Verdict
These tools offer adjacent but distinct functionalities within cardiology AI. SENSICARDIAC specializes in AI-powered heart murmur detection using electronic stethoscope data for initial screening, while Us2.ai provides fully automated, comprehensive echocardiography analysis from imaging data for detailed cardiac assessment. Therefore, they serve different diagnostic needs and workflows within cardiac care.
Choose SENSICARDIAC if…
Choose SENSICARDIAC if your primary need is an initial, AI-powered screening tool for heart murmurs, especially in remote or primary care settings. This solution is ideal for physicians looking to quickly classify murmurs as pathological or physiological using electronic stethoscopes, thereby reducing unnecessary specialist referrals and enhancing early detection.
View SENSICARDIAC →Choose Us2.ca if…
Choose Us2.ca if your focus is on fully automating and standardizing the detailed analysis of echocardiograms to enhance diagnostic accuracy and workflow efficiency. This platform is best suited for cardiology departments and imaging centers requiring comprehensive, structured cardiac reports with AI-powered disease detection, seamlessly integrating with existing PACS and EMR systems.
View Us2.ca →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | SENSICARDIAC | Us2.ca |
|---|---|---|
| Pricing | Unknown | Contact for pricing |
| Deployment | SensiCardiac is a software package running on a Windows PC that interfaces with compatible electronic stethoscopes. SensiCardiac Mobi runs on a mobile device (iPhone 4S or later) and interfaces with a hosted Linux server environment. The related Telesensi platform operates entirely in the browser. | Cloud, On-premise |
| FDA Status | Cleared AI-estimated | Yes AI-estimated |
| HIPAA | Yes AI-estimated | Yes AI-estimated |
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | SENSICARDIAC | Us2.ca |
|---|---|---|
| Name | SENSICARDIAC | Us2.ca |
| Company | DIACOUSTIC MEDICAL (PTY) | Eko.Ai Pte Ltd. D/B/A Us2.Ai |
| Description | AI-powered, cloud-based heart murmur detection service that integrates with electronic stethoscopes to classify murmurs as pathological or physiological, aiding physicians in diagnosis and reducing unnecessary referrals. | An FDA-cleared and CE-marked AI platform that fully automates echocardiography analysis, delivering comprehensive, structured cardiac reports in seconds to enhance diagnostic accuracy and and workflow efficiency. |
| Primary Function | AI-powered heart murmur detection and classification | Fully automated echocardiography analysis |
| Key Integrations | Electronic stethoscopes (e.g., 3M Littmannu00ae 3200) | Ultrasound devices, PACS, CVIS, and EMR |
| Specialties | Cardiology, Internal Medicine, Pediatrics | Cardiology, Radiology |
Videos
Demos, reviews, and walkthroughs featuring SENSICARDIAC and Us2.ca.
Loading videos…
Videos need JavaScript to load. Search YouTube directly →
Frequently Asked Questions
SENSICARDIAC integrates with electronic stethoscopes for real-time, guided auscultation, classifying murmurs to aid in initial diagnosis and reduce unnecessary referrals. Us2.ai fully automates echocardiography analysis, generating comprehensive reports from DICOM uploads in seconds, fitting into existing PACS, CVIS, and EMR workflows to enhance diagnostic accuracy for conditions like heart failure and cardiac amyloidosis.
SENSICARDIAC provides downloadable PDF cardiac reports, suggesting integration primarily for report export. Us2.ai offers deeper integration with ultrasound devices, PACS, CVIS, and EMR systems via standard DICOM routing, supporting HL7 and DICOM SR for seamless exchange of automated measurements and structured reports directly into patient records.
SENSICARDIAC states its algorithm analyzes recordings against a large validated database of pathological heart murmurs, with white papers available upon request for detailed validation. Us2.ai is extensively validated by over 63 peer-reviewed publications across global multi-center studies, demonstrating high accuracy and sensitivity for various echocardiographic parameters and disease detection, with agreement at or above inter-reader variability.
SENSICARDIAC features a guided auscultation process and real-time analysis, suggesting a straightforward learning curve for immediate use. Us2.ai is designed for 'zero clicks' and provides training sessions to ensure user comfort, with studies indicating effective use by sonographers and even those with minimal echo training, thereby streamlining adoption.
SENSICARDIAC's provided information does not explicitly detail specific audit-trail features beyond generating downloadable reports. Us2.ai offers comprehensive audit logging for all system access and actions, including for core lab solutions and clinical trials, and provides explainable AI with editable annotations to support clinical review and accountability.
SENSICARDIAC offers scalable business models with centralized user management and integrated billing for multiple facilities. Us2.ai supports multi-site deployment through cloud and on-premise options, integrating with existing PACS, CVIS, and EMR systems via standard DICOM routing, making it highly scalable and vendor-neutral for diverse imaging environments.
DIACOUSTIC MEDICAL implies support through the availability of white papers for product functionality and compliance details. Us2.ai provides direct contact for clinical demos and implementation support, and its extensive network of partnerships with major healthcare technology companies and academic medical centers serves as strong evidence of customer validation and ongoing support.